STAT3 and hepatocellular carcinoma: Finally, Oxysophocarpine decreased the FGL1 expression through downregulating IL‐6‐mediated JAK2/STAT3 axis to sensitize the anti‐Lag‐3 immunotherapy effect against HCC.